<DOC>
	<DOCNO>NCT02108509</DOCNO>
	<brief_summary>The purpose study define prevalence low bone density ( osteopenia/osteoporosis ) patient chronic pancreatitis . Secondary aim include investigate prevalence hypogonadism ( low sex hormone ) patient chronic pancreatitis determine hypogonadism and/or use narcotic pain medication risk factor low bone density patient population . 1 . Hypothesis : Patients chronic pancreatitis increase risk low bone density ( osteopenia/osteoporosis ) , hypogonadism ( low sex hormone level ) narcotic pain medication use independent risk factor development low bone density patient population . 2 . The outcome measure include : ) Prevalence low bone density ( osteopenia/osteoporosis ) patient chronic pancreatitis ( determine DXA scan fracture history ) . ii ) Prevalence hypogonadism ( low sex hormone ) patient chronic pancreatitis ( determine sex hormone level clinical history ) . iii ) Identification hypogonadism and/or opioid use risk factor low bone density patient chronic pancreatitis ( determined univariate multivariate analysis multiple risk factor ) . 3 . After obtain write consent potential subject , questionnaire perform outline risk factor low bone density . Dual X-ray absorptiometry ( DXA scan ) perform evaluate low bone density blood test perform evaluate low sex hormone , low level vitamin D , risk factor low bone density .</brief_summary>
	<brief_title>Bone Disease Chronic Pancreatitis : A Complex Phenomenon</brief_title>
	<detailed_description>Chronic pancreatitis define continue inflammatory disease pancreas characterize irreversible morphologic change typically cause pain and/or permanent loss function . The annual incidence chronic pancreatitis Unites States 5-12 per 100,000 prevalence 50 per 100,000 person though incidence rise time . The common symptom related chronic pancreatitis include steatorrhea abdominal pain . Pain chronic pancreatitis severe debilitate opioid pain medication frequently utilized management symptom . A number chronic malabsorptive disorder , include Crohn 's disease , celiac disease , cystic fibrosis know associate decreased bone mineral density . Similarly , increase data support low bone mineral density ( osteopenia osteoporosis ) patient chronic pancreatitis , though exact mechanism remain unclear . A meta-analysis 11 observational study chronic pancreatitis report prevalence osteopenia 39.8 % osteoporosis 23.4 % , cumulative prevalence low bone density ( osteopenia osteoporosis ) almost 65 % . Interestingly , eleven study meta-analysis , eight perform Europe , two India , one South America . Some study chronic pancreatitis describe link Vitamin D deficiency risk low bone density . Other propose risk factor low bone density patient population include age , gender , malnutrition , alcohol use , smoking , variation duration pancreatitis . However , potential novel risk factor low bone density exist patient chronic pancreatitis . These factor include chronic use opioid medication hypogonadism . Opioid use prominent patient chronic pancreatitis . At least 85 % patient suffer chronic pancreatitis develop pain despite many different treatment method , many patient chronic pancreatitis get respite pain , even several year . Therefore , 50 % patient chronic pancreatitis utilize opioid medication part pain management strategy . Opioid medication use show risk factor low bone density . The exact mechanism behind opioid-induced low bone density know likely multi-factorial . To date , prevalence hypogonadism patient chronic pancreatitis unknown would expect high general population due risk factor opioid use , chronic illness , potentially malnutrition . This warrant investigation high prevalence hypogonadism could directly impact bone health cohort , mention potential effect hypogonadism quality life fertility . This research project utilize Dual X-ray absorptiometry ( DXA scan ) clinical history determine prevalence low bone density ( osteopenia/osteoporosis ) cohort ; blood draw , clinical history , questionnaire determine prevalence hypogonadism cohort ; blood draw , clinical history , questionnaire examine specific risk factor low bone density cohort . After obtain write consent potential subject , questionnaire perform outline smoke history , alcohol use history , fracture history , signs/symptoms hypogonadism , exercise pattern , opioid medication use history . A one-time Dual X-ray absorptiometry ( DXA scan ) perform subject . A one-time blood draw perform subject , follow lab test perform subject : - 25-hydroxy Vitamin D - Comprehensive Metabolic Panel - Total Testosterone ( male ) - Estradiol ( female ) - Lutenizing hormone ( LH ) - Follicle-stimulating hormone ( FSH ) - Steroid hormone bind globulin ( SHBG ) - Prolactin</detailed_description>
	<mesh_term>Osteoporosis</mesh_term>
	<mesh_term>Pancreatitis</mesh_term>
	<mesh_term>Bone Diseases</mesh_term>
	<mesh_term>Bone Diseases , Metabolic</mesh_term>
	<mesh_term>Pancreatitis , Chronic</mesh_term>
	<criteria>Age 1975 year Diagnosis Chronic Pancreatitis , define specific clinical criterion Refusal complete consent process 's entirety . Pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Chronic Pancreatitis</keyword>
	<keyword>Osteopenia</keyword>
	<keyword>Osteoporosis</keyword>
	<keyword>Hypogonadism</keyword>
	<keyword>Opioid medication</keyword>
</DOC>